IndraLab

Statements

JSH-23 inhibits IFNB1. 1 / 1

| 1

reach

"To explore whether NF-kappaB is essential for HSV-1-induced early phase IFN-beta production, we pretreated BMMs with different doses of JSH-23, a specific inhibitor of NF-kappaB nuclear translocation and transcriptional activity, 12 before BMMs were subjected to HSV-1 infection for 4 h. ELISA revealed that JSH-23 potently inhibited HSV-1-induced early phase IFN-beta production at the dose as low as 2.5 muM and the inhibitory effect became more significant when the dose increased (XREF_FIG)."

27593482

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

JSH-23 inhibits IFNB1. 1 / 1

INDRA sources:

Databases

Reading